| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Bajaj Finserv Healthcare Fund (G) Direct |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.01 |
| Derivatives/Mutual Fund/ETF |
1.60 |
| Equity |
96.71 |
| Trep |
1.70 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
37.40% |
| Top 10 Holdings |
59.13% |
| Top 25 Holdings |
89.30% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
66.46 |
| Healthcare |
18.47 |
| Retail |
3.93 |
| Food Beverage & Tobacco |
2.73 |
| Chemicals |
2.11 |
| Consumer Durables |
1.94 |
| Cash |
1.69 |
| Debt MF |
1.6 |
| Miscellaneous |
1.07 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.75 |
| PE Ratio |
49.69 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| DIVI LABORATORIES LTD |
9.10 |
| Sun Pharmaceutical Industries Limited |
9.00 |
| Aurobindo Pharma Limited |
6.57 |
| Apollo Hospitals Enterprise Limited |
6.46 |
| Piramal Pharma Limited |
6.27 |
| Torrent Pharmaceuticals Limited |
5.13 |
| Rubicon Research Limited |
4.48 |
| Emcure Pharmaceuticals Limited |
4.26 |
| Neuland Laboratories Limited |
3.96 |
| Max Healthcare Institute Limited |
3.90 |
| Fortis Health Care Ltd |
3.43 |
| EQ -ZYDUS WELLNESS LTD. |
2.73 |
| IPCA Laboratories Limited |
2.39 |
| VIJAYA DIAGNOSTIC CENTRE LIMITED |
2.16 |
| NAVIN FLUORINE INTERNATIONAL L |
2.11 |
| Glenmark Pharmaceuticals Limited |
2.07 |
| SANOFI CONSUMER HEALTHCARE |
2.04 |
| Shaily Engineering Plastics Limited |
1.94 |
| Glaxosmithkline Pharma Ltd |
1.72 |
| Clearing Corporation of India Ltd |
1.70 |
| Laurus Labs Limited |
1.70 |
| Godrej Consumer Products Limited |
1.65 |
| Bajaj Finserv Money Market Fund-Direct Plan-Growth |
1.60 |
| Dr Lal Path Labs Ltd |
1.49 |
| Lupin Limited |
1.44 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
